Endocarditis, Bacterial: Clinical Trials

2 trials for Endocarditis, Bacterial, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Terminated 2

Follow Endocarditis, Bacterial: new trials by email Literature Review of Endocarditis, Bacterial trials Research Report on Endocarditis, Bacterial

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Short-course Antibiotic Treatment in Gram-positive Cocci Infective Endocarditis
Antibiotics - Endocarditis, Bacterial
Phase 4TerminatedCarmen Olmos Blanco202021-01-262023-09-28
Daptomycin as an Adjuvant Agent in the Treatment of Enterococcal Native Valve Endocarditis.
Daptomycin - Endocarditis, Bacterial
Phase 4TerminatedWeill Medical College of Cornell University62006-09-012017-05-03

Narrower conditions

Endocarditis (2)

Broader conditions

Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Cardiovascular Diseases (2)  ·  Cardiovascular Infections (2)  ·  Heart Diseases (2)  ·  Infections (2)

Interventions

Anti-Bacterial Agents (1)  ·  Daptomycin (1)

Sponsors

Carmen Olmos Blanco (1)  ·  Weill Medical College of Cornell University (1)

Countries

Spain (1)  ·  United States (1)

Top investigators

Kyu Y Rhee, MD, PhD (1)

Results publications

PMID 32546269